Cargando…
Development of Recombinant Measles Virus-Based Vaccines
This chapter describes the development of recombinant measles virus (MV)-based vaccines starting from plasmid DNA. Live-attenuated measles vaccines are very efficient and safe. Since the availability of a reverse genetic system to manipulate MV genomes and to generate respective recombinant viruses,...
Autores principales: | Mühlebach, Michael D., Hutzler, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121886/ https://www.ncbi.nlm.nih.gov/pubmed/28374248 http://dx.doi.org/10.1007/978-1-4939-6869-5_9 |
Ejemplares similares
-
Vaccine platform recombinant measles virus
por: Mühlebach, Michael D.
Publicado: (2017) -
Versatility of live-attenuated measles viruses as platform technology for recombinant vaccines
por: Ebenig, Aileen, et al.
Publicado: (2022) -
A protective measles virus-derived vaccine inducing long-lasting immune responses against influenza A virus H7N9
por: Hörner, Cindy, et al.
Publicado: (2023) -
Reverse Genetics of Measles Virus and Resulting Multivalent Recombinant Vaccines: Applications of Recombinant Measles Viruses
por: Billeter, M. A., et al.
Publicado: (2009) -
93. Novel recombinant measles virus vaccine prevents measles virus disease in rhesus macaques
por: Rubens, Jessica, et al.
Publicado: (2022)